Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Carbapenems reported by Merck & Co.

Sep. 6, 1996

Merck & Co. describes antibiotics active against resistant staphylococci

Sep. 6, 1996

Japanese companies report cephems

Sep. 6, 1996

NSC-665158: HIV-1 reverse transcriptase inhibitor analogue

Aug. 30, 1996

Antiherpes compounds from Bio-Mega/Boehringer Ingelheim

Aug. 30, 1996

Influenza A virus sialidase inhibitors from Glaxo Wellcome

Aug. 30, 1996

Tetromycin A: a novel antibacterial agent

Aug. 30, 1996

Antifungal agents from Hokko Kagaku

Aug. 30, 1996

Dura obtains marketing rights of Lilly's cephalosporin antibiotics

Aug. 30, 1996

Erythromycin A 9-O-oxime derivatives from Zambon

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...